血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2022 BSH指南：华氏巨球蛋白血症的诊断和管理

2022-01-12 英国血液病学学会 Br J Haematol

华氏巨球蛋白血症淋巴|免疫

2022年1月，英国血液病学学会(BSH)发布了华氏巨球蛋白血症的诊断和管理指南，文章主要目的是为医疗专业人员提供关于华氏巨球蛋白血症患者管理的明确指导建议，主要涉及诊断和治疗的相关内容。

中文标题：

2022 BSH指南：华氏巨球蛋白血症的诊断和管理

英文标题：

Guidelines on the diagnosis and management of Waldenström macroglobulinaemia-A British Society for Haematology guideline

发布机构：

英国血液病学学会

发布日期：

2022-01-12

简要介绍：

2022年1月，英国血液病学学会(BSH)发布了华氏巨球蛋白血症的诊断和管理指南，文章主要目的是为医疗专业人员提供关于华氏巨球蛋白血症患者管理的明确指导建议，主要涉及诊断和治疗的相关内容。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 BSH指南：华氏巨球蛋白血症的诊断和管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=511671c002319a9f, title=2022 BSH指南：华氏巨球蛋白血症的诊断和管理, enTitle=Guidelines on the diagnosis and management of Waldenström macroglobulinaemia-A British Society for Haematology guideline, guiderFrom=Br J Haematol, authorId=0, author=, summary=2022年1月，英国血液病学学会(BSH)发布了华氏巨球蛋白血症的诊断和管理指南，文章主要目的是为医疗专业人员提供关于华氏巨球蛋白血症患者管理的明确指导建议，主要涉及诊断和治疗的相关内容。, cover=https://img.medsci.cn/2022113/1642044861418_1608702.jpg, journalId=0, articlesId=null, associationId=1339, associationName=英国血液病学学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Jan 12 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年1月，英国血液病学学会(BSH)发布了华氏巨球蛋白血症的诊断和管理指南，文章主要目的是为医疗专业人员提供关于华氏巨球蛋白血症患者管理的明确指导建议，主要涉及诊断和治疗的相关内容。</span></p>, tagList=[TagDto(tagId=39132, tagName=华氏巨球蛋白血症), TagDto(tagId=117103, tagName=淋巴|免疫)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5409, appHits=122, showAppHits=0, pcHits=940, showPcHits=5287, likes=1, shares=12, comments=5, approvalStatus=1, publishedTime=Thu Jan 13 11:31:50 CST 2022, publishedTimeString=2022-01-12, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Thu Jan 13 11:36:39 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 19:01:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 BSH指南：华氏巨球蛋白血症的诊断和管理.pdf)])
2022 BSH指南：华氏巨球蛋白血症的诊断和管理.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1226590, encodeId=a5e812265903a, content=正需要，非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb2a8203883, createdName=ms8000000291665724, createdTime=Wed Jun 15 14:13:47 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184464, encodeId=0204118446472, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 15 07:23:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184050, encodeId=89c61184050af, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200825/7604133fa4724e12bf9b0b771bb0480f/066d4f0aa17148c59fb04649d7905189.jpg, createdBy=11823001903, createdName=积极向上的青年, createdTime=Thu Jan 13 22:24:26 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183868, encodeId=2c85118386802, content=好东西，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Thu Jan 13 13:16:15 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-06-15 ms8000000291665724

    正需要，非常感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1226590, encodeId=a5e812265903a, content=正需要，非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb2a8203883, createdName=ms8000000291665724, createdTime=Wed Jun 15 14:13:47 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184464, encodeId=0204118446472, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 15 07:23:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184050, encodeId=89c61184050af, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200825/7604133fa4724e12bf9b0b771bb0480f/066d4f0aa17148c59fb04649d7905189.jpg, createdBy=11823001903, createdName=积极向上的青年, createdTime=Thu Jan 13 22:24:26 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183868, encodeId=2c85118386802, content=好东西，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Thu Jan 13 13:16:15 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-01-15 微探

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1226590, encodeId=a5e812265903a, content=正需要，非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb2a8203883, createdName=ms8000000291665724, createdTime=Wed Jun 15 14:13:47 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184464, encodeId=0204118446472, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 15 07:23:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184050, encodeId=89c61184050af, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200825/7604133fa4724e12bf9b0b771bb0480f/066d4f0aa17148c59fb04649d7905189.jpg, createdBy=11823001903, createdName=积极向上的青年, createdTime=Thu Jan 13 22:24:26 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183868, encodeId=2c85118386802, content=好东西，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Thu Jan 13 13:16:15 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-01-13 积极向上的青年

    学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1226590, encodeId=a5e812265903a, content=正需要，非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb2a8203883, createdName=ms8000000291665724, createdTime=Wed Jun 15 14:13:47 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184464, encodeId=0204118446472, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Jan 15 07:23:01 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184050, encodeId=89c61184050af, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200825/7604133fa4724e12bf9b0b771bb0480f/066d4f0aa17148c59fb04649d7905189.jpg, createdBy=11823001903, createdName=积极向上的青年, createdTime=Thu Jan 13 22:24:26 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183868, encodeId=2c85118386802, content=好东西，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0be2111725, createdName=萌宝嘟嘟, createdTime=Thu Jan 13 13:16:15 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-01-13 萌宝嘟嘟

    好东西，谢谢分享

    0

相关指南

“淋巴浆细胞淋巴瘤/华氏巨球蛋白血症诊断与治疗中国专家共识(2016年版)”解读

暂未更新 · 2017-09-30

2016 淋巴浆细胞淋巴瘤/华氏巨球蛋白血症诊断与治疗中国专家共识

中华医学会血液学分会白血病淋巴瘤学组 · 2016-09-30